These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6417018)

  • 1. Interaction of a rat lung lectin with the exopolysaccharides of Pseudomonas aeruginosa.
    McArthur HA; Ceri H
    Infect Immun; 1983 Nov; 42(2):574-8. PubMed ID: 6417018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, secretion, and bacterial specificity of an endogenous lectin from cystic fibrosis lung.
    Ceri H; Hwang WS; Rabin H
    Am J Respir Cell Mol Biol; 1991 Jul; 5(1):51-5. PubMed ID: 1715177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of alginate from Pseudomonas aeruginosa with two forms of heparin-binding lectin isolated from rat lung.
    Ceri H; McArthur HA; Whitfield C
    Infect Immun; 1986 Jan; 51(1):1-5. PubMed ID: 3079726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa.
    Pier GB; Matthews WJ; Eardley DD
    J Infect Dis; 1983 Mar; 147(3):494-503. PubMed ID: 6220094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum.
    Speert DP; Lawton D; Mutharia LM
    Pediatr Res; 1984 May; 18(5):431-3. PubMed ID: 6233529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical examination of the Pseudomonas aeruginosa glycocalyx: a monoclonal antibody which recognizes L-guluronic acid residues of alginic acid.
    Irvin RT; Ceri H
    Can J Microbiol; 1985 Mar; 31(3):268-75. PubMed ID: 3924383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyclonal B cell stimulation and interleukin 1 induction by the mucoid exopolysaccharide of Pseudomonas aeruginosa associated with cystic fibrosis.
    Daley L; Pier GB; Liporace JD; Eardley DD
    J Immunol; 1985 May; 134(5):3089-93. PubMed ID: 3920310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine.
    Pier GB; DesJardin D; Grout M; Garner C; Bennett SE; Pekoe G; Fuller SA; Thornton MO; Harkonen WS; Miller HC
    Infect Immun; 1994 Sep; 62(9):3972-9. PubMed ID: 8063415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
    Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
    N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay.
    Bryan LE; Kureishi A; Rabin HR
    J Clin Microbiol; 1983 Aug; 18(2):276-82. PubMed ID: 6413528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
    Hatano K; Goldberg JB; Pier GB
    Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis.
    Pedersen SS; Møller H; Espersen F; Sørensen CH; Jensen T; Høiby N
    APMIS; 1992 Apr; 100(4):326-34. PubMed ID: 1581041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
    Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
    J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysaccharide antigens of Pseudomonas aeruginosa.
    Pier GB
    Rev Infect Dis; 1988; 10 Suppl 2():S337-40. PubMed ID: 3142017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
    Pressler T
    APMIS Suppl; 1996; 66():1-41. PubMed ID: 8972694
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudomonas aeruginosa surface polysaccharide vaccines. New therapeutic approaches from basic research.
    Pier GB
    Antibiot Chemother (1971); 1985; 36():157-67. PubMed ID: 3923913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing.
    Leid JG; Willson CJ; Shirtliff ME; Hassett DJ; Parsek MR; Jeffers AK
    J Immunol; 2005 Dec; 175(11):7512-8. PubMed ID: 16301659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa.
    Pier GB; Thomas DM
    J Infect Dis; 1982 Feb; 145(2):217-23. PubMed ID: 6798136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.
    Kronborg G; Fomsgaard A; Galanos C; Freudenberg MA; Høiby N
    J Clin Microbiol; 1992 Jul; 30(7):1848-55. PubMed ID: 1378455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction.
    Pier GB
    J Infect Dis; 1985 Apr; 151(4):575-80. PubMed ID: 3919113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.